Literature DB >> 5581079

Acid degradation of erythromycin A and erythromycin B.

P Kurath, P H Jones, R S Egan, T J Perun.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5581079     DOI: 10.1007/BF02137246

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  1 in total

1.  Chemistry of erythronolide B. Acid-catalyzed transformations of the aglycone of erythromycin B.

Authors:  T J Perun
Journal:  J Org Chem       Date:  1967-07       Impact factor: 4.354

  1 in total
  20 in total

1.  Blood, tissue, and intracellular concentrations of erythromycin and its metabolite anhydroerythromycin during and after therapy.

Authors:  S Krasniqi; P Matzneller; M Kinzig; F Sörgel; S Hüttner; E Lackner; M Müller; M Zeitlinger
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

Review 2.  New directions for macrolide antibiotics: structural modifications and in vitro activity.

Authors:  H A Kirst; G D Sides
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

3.  In vitro activity and in vivo efficacy of a new series of 9-deoxo-12-deoxy-9,12-epoxyerythromycin A derivatives.

Authors:  D J Hardy; R N Swanson; N L Shipkowitz; L A Freiberg; P A Lartey; J J Clement
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

4.  Fluorescence polarization method to characterize macrolide-ribosome interactions.

Authors:  Kang Yan; Eric Hunt; John Berge; Earl May; Robert A Copeland; Richard R Gontarek
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

Review 5.  Natural Products as Platforms To Overcome Antibiotic Resistance.

Authors:  Sean E Rossiter; Madison H Fletcher; William M Wuest
Journal:  Chem Rev       Date:  2017-09-27       Impact factor: 60.622

6.  Effect of erythromycin analogues on binding of [14C]erythromycin to Escherichia coli ribosomes.

Authors:  S Pestka; R A Lemahieu
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

7.  In vitro induction of resistance to erythromycin by its metabolite.

Authors:  J Majer
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

8.  Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides.

Authors:  L Wondrack; M Massa; B V Yang; J Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

9.  Erythromycin resistance and the chloroplast ribosome in Chlamydomonas reinhardi.

Authors:  J N Davidson; M R Hanson; L Bogorad
Journal:  Genetics       Date:  1978-06       Impact factor: 4.562

Review 10.  The evolving role of chemical synthesis in antibacterial drug discovery.

Authors:  Peter M Wright; Ian B Seiple; Andrew G Myers
Journal:  Angew Chem Int Ed Engl       Date:  2014-07-02       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.